Collaborative study of a control standard endotoxin using the Limulus amebocyte (gel-clot) test

Area of Science:

• Microbiology
• Pharmacology
• Biotechnology

Background:

• Endotoxins are critical pyrogens in pharmaceutical products, necessitating accurate quantification.
• Standardization of endotoxin quantification is vital for ensuring drug safety and efficacy.
• Existing reference standards, USP EC-5 (EU) and WHO (IU), are essential for comparative analysis.

Purpose of the Study:

• To determine the potency of a control standard endotoxin (CSE), LIF-1, in both Endotoxin Units (EU) and International Units (IU).
• To establish a precise conversion factor between EU and IU for endotoxin quantification.
• To validate the use of a modified Limulus Amebocyte Lysate (LAL) gel-clot test protocol for enhanced accuracy.

Main Methods:

• A collaborative study involving five laboratories from the Swedish Pharmaceutical Industry.
• Utilized USP reference standard endotoxin (EC-5) and WHO international standard endotoxin as references.
• Employed the Limulus Amebocyte Lysate (LAL) gel-clot assay with a 1:1.25 step dilution method for increased precision.

Main Results:

• The potency of LIF-1 (CSE) was calculated as 22 EU and 16 IU per vial.
• Established a conversion ratio: 1 EU (USP) corresponds to 0.7 IU (WHO).
• The modified dilution method yielded more precise and standardized results compared to conventional methods.

Conclusions:

• The study successfully quantified the potency of the control standard endotoxin (LIF-1) in both EU and IU.
• A reliable conversion factor between EU and IU was established, aiding in global endotoxin standardization.
• The optimized LAL gel-clot test protocol demonstrates improved accuracy and reproducibility for endotoxin determination.